Stocklytics Platform
Asset logo for symbol BNGO
BioNano Genomics
BNGO64
$0.42arrow_drop_up5.00%$0.02
Penny Stock
Asset logo for symbol BNGO
BNGO64

$0.42

arrow_drop_up5.00%

Performance History

Chart placeholder
no data available for key stats

There's no data available for key stats

no data available for ratios/profitability stats

There's no data available for ratios/profitability stats

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About BioNano Genomics (BNGO)

BioNano Genomics Inc (BNGO) is a leading life sciences company that specializes in the development and commercialization of genomic analysis instruments. The company's flagship product, the Saphyr System, is a high-resolution optical mapping instrument that provides researchers with a comprehensive view of the genome at the single-molecule level. This cutting-edge technology enables a wide range of applications, including the detection of structural variations, genome assembly, and the analysis of complex diseases.
The Saphyr System offers several advantages over traditional sequencing technologies. It can provide long-range structural information that is not accessible by other methods, allowing researchers to identify large-scale genomic rearrangements and gain insight into the mechanisms underlying disease. The instrument is also highly accurate, with a low error rate and the ability to detect even subtle genetic variations. This makes it a valuable tool for both research and clinical applications.
Sector
Healthcare
Industry
Medical Instruments & Supplies
CEO
Dr. Robert Erik Holmlin M.B.A., Ph.D.
Headquarters
San Diego
Employees
405
Exchange
NASDAQ
add BioNano Genomics  to watchlist

Keep an eye on BioNano Genomics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is BioNano Genomics 's (BNGO) price per share?

The current price per share for BioNano Genomics (BNGO) is $0.42. The stock has seen a price change of $0.02 recently, indicating a 5% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for BioNano Genomics (BNGO)?

For BioNano Genomics (BNGO), the 52-week high is $3.13, which is 645.24% from the current price. The 52-week low is $0.31, the current price is 35.48% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is BioNano Genomics (BNGO) a growth stock?

BioNano Genomics (BNGO) has shown an average price growth of 0.41% over the past three years. It has received a score of -3 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying BioNano Genomics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is BioNano Genomics (BNGO) stock price performance year to date (YTD)?

As of the latest data, BioNano Genomics (BNGO) has a year-to-date price change of -79%. Over the past month, the stock has experienced a price change of -24.61%. Over the last three months, the change has been -47.81%. Over the past six months, the figure is -59.62%. Looking at a longer horizon, the five-year price change stands at -95.04%.
help

Is BioNano Genomics (BNGO) a profitable company?

BioNano Genomics (BNGO) has a net income of -$232.49M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 26.49% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -203.36% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , with a revenue growth rate of 29.9%, providing insight into the company's sales performance and growth. The gross profit is $9.57M. Operating income is noted at -$139.43M. Furthermore, the EBITDA is -$91.42M.
help

What is the market capitalization of BioNano Genomics (BNGO)?

BioNano Genomics (BNGO) has a market capitalization of $34.42M. The average daily trading volume is 1.1M, indicating the stock's liquidity and investor engagement.

News

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media